VAERS reports by lot

GSK Varicella/Shingles lot 9LG54: VAERS reports

55 VAERS reports list lot 9LG54 as a GSK Varicella/Shingles vaccine, received between 2019-06-01 and 2023-02-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5124%
Injection-site / Local reaction5124%
Musculoskeletal3416%
Dermatological (non-injection-site)2311%
Neurological199%
Gastrointestinal94%
Allergic / Anaphylactic84%
Psychiatric / Neuropsychiatric52%
Cardiac / Cardiovascular42%
Respiratory42%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina6
Pennsylvania6
Florida5
New Jersey4
Indiana4
Georgia3
Massachusetts3
Michigan3
Ohio3
Rhode Island2
Maryland2
Illinois2

Reports by month received

2019-0621
2019-0717
2019-088
2019-093
2019-112
2020-011
2020-061
2021-021
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.